Pds Biotechnology CORP Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Nant Capital, led by Patrick Soon-Shiong, has acquired a significant stake in PDS Biotechnology Corporation, securing board seats and an option for exclusive licensing negotiations.